The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.
about
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.Results of the two incidence screenings in the National Lung Screening Trial.Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer).Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.New challenges for comparative effectiveness in oncology: choice of primary end points for randomized clinical trials.Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial?
P2860
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The National Lung Screening Tr ...... etermining the cause of death.
@ast
The National Lung Screening Tr ...... etermining the cause of death.
@en
type
label
The National Lung Screening Tr ...... etermining the cause of death.
@ast
The National Lung Screening Tr ...... etermining the cause of death.
@en
prefLabel
The National Lung Screening Tr ...... etermining the cause of death.
@ast
The National Lung Screening Tr ...... etermining the cause of death.
@en
P2093
P2860
P1476
The National Lung Screening Tr ...... etermining the cause of death.
@en
P2093
Anthony B Miller
Christine D Berg
Jennifer Rosenbaum
Kristen Keating
Pamela M Marcus
P2860
P304
P356
10.1016/J.CCT.2011.07.003
P407
P577
2011-07-18T00:00:00Z